This site is intended for Healthcare Professionals only

endometrial cancer

Endometrial adenocarcinoma summary.jpg

Life extending endometrial cancer drug rolled out on NHS

Dostarlimab recommended as a second line treatment for use within the Cancer Drugs Fund.

15 Feb 2022 , 1 Min Article

Change privacy settings